S. Africa regards BHP bid typical market activity    Egypt auctions EGP 6b zero coupon t-bonds    Sisi announces direct flights between Egypt, Bosnia    Gulf stock markets rise on strong earnings    Oil declines in early Monday trade    $1.8bn in payment orders issued for tax-free car import initiative    Main Marks Developments signs agreement with Misr Company, Retaj Hotels for MORAY project    AAIB-NBE alliance grants Roya Developments EGP 5.6bn loan    Sweilam highlights Egypt's water needs, cooperation efforts during Baghdad Conference    AstraZeneca, Ministry of Health launch early detection and treatment campaign against liver cancer    AstraZeneca injects $50m in Egypt over four years    Egypt, AstraZeneca sign liver cancer MoU    US to withdraw troops from Chad, Niger amid shifting alliances    Africa's youth called on to champion multilateralism    AU urges ceasefire in Western Sudan as violence threatens millions    Negativity about vaccination on Twitter increases after COVID-19 vaccines become available    US student protests confuse White House, delay assault on Rafah    Environment Ministry, Haretna Foundation sign protocol for sustainable development    Swiss freeze on Russian assets dwindles to $6.36b in '23    Amir Karara reflects on 'Beit Al-Rifai' success, aspires for future collaborations    Climate change risks 70% of global workforce – ILO    Prime Minister Madbouly reviews cooperation with South Sudan    Ramses II statue head returns to Egypt after repatriation from Switzerland    Egypt retains top spot in CFA's MENA Research Challenge    Egyptian public, private sectors off on Apr 25 marking Sinai Liberation    Egypt forms supreme committee to revive historic Ahl Al-Bayt Trail    Debt swaps could unlock $100b for climate action    President Al-Sisi embarks on new term with pledge for prosperity, democratic evolution    Amal Al Ghad Magazine congratulates President Sisi on new office term    Egyptian, Japanese Judo communities celebrate new coach at Tokyo's Embassy in Cairo    Uppingham Cairo and Rafa Nadal Academy Unite to Elevate Sports Education in Egypt with the Introduction of the "Rafa Nadal Tennis Program"    Financial literacy becomes extremely important – EGX official    Euro area annual inflation up to 2.9% – Eurostat    BYD، Brazil's Sigma Lithium JV likely    UNESCO celebrates World Arabic Language Day    Motaz Azaiza mural in Manchester tribute to Palestinian journalists    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Egypt among worst hit by viral Hepatitis
Published in Daily News Egypt on 02 - 05 - 2007

National strategy to cut prevalence below 5%, a media campaign to be launched
CAIRO: US and Egyptian scientists participating at the 14th annual AUC Research Conference warned against the impact of economic, social and psychological problems caused by the high prevalence of Hepatitis C (HCV) in Egypt.
Egypt, along with Magnolia and Bolivia, is amongst the worst hit by the virus and has the world s highest prevalence rate ranging from 12 to 15 percent and up to 18 percent of the population in rural areas.
Dr. F. DeWolfe Miller, head of the Public Health Sciences and Epidemiology at the University of Hawaii, gave the keynote speech at this year s conference.
He referred to a study conducted by The Lancet Medical Journal in 2000, in cooperation with the World Health Organization and the Egyptian Ministry of Health that traced the prevalence of the virus in Egypt to mass treatment campaigns implemented to fight Schistosomiasis, a condition caused by a parasite in the blood acquired through swimming in contaminated irrigation canals in rural areas.
He said the mass anti-Schistosomal injection treatment campaign carried out between the 1950s and 1980s, long before the exposure to blood was clearly understood and before disposable syringes were available, was the cause of the high prevalence of HCV in Egypt.
Miller described, in a lecture entitled The Epidemiology of Hepatitis C in Egypt, the medical challenges that HCV poses due to its high replication and mutation rate is comparable to that of the HIV virus which causes AIDS.
He said this small, only recently imaged virus, also poses huge challenges when it comes to detection and prevention of its spread from an infected person to others mainly through blood contact, as the virus has an incubation period of three to 20 weeks before the infected person starts showing symptoms of the disease.
There are a number of windows of opportunity for an infected person to transmit the virus without even knowing it, as the appearance of the virus in the blood could occur long before any manifestation of symptoms . also determining if a person is infected based on an antibodies test may not be possible as antibodies may not appear until after the virus is already in the blood, said Miller, who has been working on HCV in Egypt since 1975.
Miller, who co-discovered the epidemic in Egypt, recounted how the world s biggest Hepatitis epidemic was discovered in Egypt in the early 1980s. This was after a microbiologist conducting research on local and foreign labor groups in Saudi Arabia found an unusually high number of Egyptian workers testing positive for HCV.
Since that time, much has been done by the health authorities in Egypt to remove blood tainted with the virus from the blood supply used for blood transfusion, and I can attest that procedures taken by the Vacsera [the main health body in charge of vaccination and serums] in Egypt are very, very, very good, he said.
Egyptian scientists taking part in the three-day conference that started on April 28, called for amending legislation to allowing cadaveric liver transplants, or organ transplant from recently dead healthy donors.
They criticized the fact that Egyptian law only allows living donor transplants, and pinned hopes on a national campaign to prevent the transmission of the disease and cut its prevalence in Egypt to less than five percent.
Panelist Gamal Esmat, a professor of tropical medicine at the Faculty of Medicine and director of the Hematology Research Unit at Cairo University, told The Daily Star Egypt that the five-year national strategy aims to prevent the iatrogenic transmission of the disease by focusing on medical behavior to ensure safe medical procedures are followed by dentists.
There are also plans for a national survey to assess the impact of the disease and its transmission on the socio-economic level. We started a treatment applicability program to attempt to eliminate the reservoir of virus in infected people in Cairo, Alexandria and Assiut to prevent the spread of the infection.
Esmat also pointed out that the national strategy will launch a community study to minimize the risk factors of contracting HCV from barbers, body art, such as tattoos, and body piercing, through a media and awareness campaign.
We hope by the end of these five years to succeed in reducing the prevalence of HCV from more than 10 percent to less than five percent.
Another panelist, Dr. Amr Helmy, a professor of Surgery at The National Liver Institute, in Egypt's Menufiya University, called for changing the law to allow cadaveric liver transplants from a dead donor to a living receptor, as surgery remains the gold standard for treatment of Hepatitis C in its advanced stages, marked by extensive morbidity and liver damage on the cellular level.
The obstacle to the success of the surgical solution to the epidemic are ethical, legal, financial, and social rather than medical, he said.
Helmy noted that while an elective transplant from a living donor, usually a family member, to a hepatitis patient has the advantage of being a clean transplant, the procedure is still marred by disadvantages such as limited eligibility, the risk of donor mortality, psychological and social limitations, in addition to the absence of a clear understanding of the long-term health impacts on the donor, as the first ever procedure of this kind was only carried out in 1990.
On the other hand, limitations to cadaveric transplants are the lack of legislation, lack of equipped rescue units, trained mobile medical teams, and advanced communications and transfer systems, he added.
HCV: Facts and Figures
. Nearly 200 million or two percent of the global population are infected with HCV; Egypt has the world s highest prevalence of more than 12 percent of the population.
. Prevalence in developed countries does not exceed two percent, while it ranges from three to four percent in India and China.
. HVC is blood borne; at highest risk are drug users who share needles, those who have had a blood transfusion or an organ transplant before 1992.
. Body piercing, tattooing, acupuncture, and dental procedures can transmit the virus.
. Sexual contact has not been fully established as a sure transmission route.
. Hepatitis A and E are self-limiting and are transmitted through contaminated food or water.
. Diagnosis and the interpretation of blood tests is complex; over 80 percent of Hepatitis C patients have no symptoms.
. The cost of a live donor liver transplant in private hospitals increased from LE 80,000 in 1991 to LE 400,000. Cost of the procedure in government, charity, or university hospitals currently stands at LE 150,000.
. Egypt spends LE 1.3 billion annually to treat diabetes and cancer. However, diabetes and cancer patients have lower chances for full productive lives after treatment compared to Hepatitis patients who receive a live transplant. For the same amount of funding allotted to diabetes and cancer, 1,000 liver transplant procedures could be performed each year.


Clic here to read the story from its source.